Heart Test Laboratories(HSCS) - 2025 Q1 - Quarterly Results

Filing Information This chapter provides general details about the Form 8-K filing and the company's emerging growth status General Details This Form 8-K was filed by Heart Test Laboratories, Inc. on September 12, 2024, to report current events. The company's common stock and warrants are traded on The Nasdaq Stock Market LLC under symbols HSCS and HSCSW, respectively - Heart Test Laboratories, Inc. filed a Form 8-K on September 12, 2024[1] Common Stock and Warrants Trading Information | Trading Symbol(s) | Name of each exchange on which registered | | :---------------- | :-------------------------------------- | | HSCS | The Nasdaq Stock Market LLC | | HSCSW | The Nasdaq Stock Market LLC | Emerging Growth Company Status Heart Test Laboratories, Inc. has indicated its status as an 'emerging growth company' as defined under the Securities Act of 1933 and the Securities Exchange Act of 1934 - The registrant is an 'emerging growth company'[2] Item 2.02 Results of Operations and Financial Condition This section details the company's financial and operating results for the quarter ended July 31, 2024, as disclosed in a press release Summary of Financial and Operating Results Heart Test Laboratories, Inc. issued a press release on September 12, 2024, detailing its financial and operating results for the quarter ended July 31, 2024, along with other business updates. This press release is furnished as Exhibit 99.1 to this Form 8-K - Heart Test Laboratories, Inc. issued a press release on September 12, 2024, providing financial and operating results for the quarter ended July 31, 2024[3] - The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K[3] - Information in Item 2.02 and Exhibit 99.1 is not deemed 'filed' for Section 18 of the Exchange Act, unless expressly incorporated by reference[3] Item 9.01 Financial Statements and Exhibits This section lists the exhibits accompanying the Form 8-K filing, including the press release and interactive data file Exhibits List This section lists the exhibits accompanying the Form 8-K filing, which include the press release detailing financial results and the interactive data file for the cover page Form 8-K Exhibits | Exhibit No. | Description | | :---------- | :---------------------------------------------- | | 99.1 | Press Release dated September 12, 2024 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | Signatures This chapter confirms the due signing of the report by authorized personnel on behalf of Heart Test Laboratories, Inc. Authorization and Signing The report was duly signed on September 12, 2024, on behalf of Heart Test Laboratories, Inc. by Andrew Simpson, who holds the titles of President, Chief Executive Officer, and Chairman of the Board of Directors - The report was signed on September 12, 2024[4] - Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board of Directors, signed the report[4]